Veille Scientifique

La veille scientifique est un nouveau service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie Foie/
VB
Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS
T. APARICIO
B. DENIS
S. MANFREDI
Y. TOUCHEFEU
D. TOUGERON

C. CELLIER
E. CHABRUN
F. ROSTAIN
JM. ROUILLON

B. HANSLIK
JL. PAYEN
JM. PERON
D. VALLA

H. DAMON
P. DUCROTTE
F. CORDET
V. COSTIL
P. COULOM
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
P. MARTEAU
B. PARIENTE
P. SEKSIK
M. CAMUS-DUBOC
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
Gastrointestinal Endoscopy Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States. oct. 17 4 ♥ Endoscopie - Imagerie
Gut Deep mural injury and perforation after colonic endoscopic mucosal resection: a new classification and analysis of risk factors oct. 17 3 ♥ Endoscopie - Imagerie
Gastroenterology Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy. oct. 17 3 ♥ Cancer colorectal (CCR)
Journal of the American Medical Association (JAMA) Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer The ROLARR Randomized Clinical Trial oct. 17 5 ♥ Coloproctologie
Journal of the American Medical Association (JAMA) Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer The ROLARR Randomized Clinical Trial oct. 17 5 ♥ Coloproctologie
Gut Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms oct. 17 4 ♥ Pancréas/Voies biliaires
Journal of clinical oncology (JCO) CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial. oct. 17 3 ♥ Pancréas/Voies biliaires
Journal of clinical oncology (JCO) Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma oct. 17 4 ♥ Pancréas/Voies biliaires
Journal of Crohn's and Colitis Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial. oct. 17 3 ♥ MICI
Journal of Crohn's and Colitis Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy. oct. 17 3 ♥ MICI
Journal of the National Cancer Institute (JNCI) Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma oct. 17 3 ♥ Carcinome hépatocellaire (CHC)
British journal of Cancer First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial oct. 17 3 ♥ Cancer colorectal (CCR)
Gut Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. oct. 17 3 ♥ Cancer colorectal (CCR)
The Lancet Oncology TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study. sep. 17 2 ♥ Cancer colorectal (CCR)
The Lancet Oncology Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. sep. 17 4 ♥ Cancer colorectal (CCR)
Gut Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity. sep. 17 4 ♥ Foie
Colorectal Disease Systematic Review and Meta-Analysis of the Role of Metronidazole in Post-Haemorrhoidectomy Pain Relief. sep. 17 4 ♥ Coloproctologie (hors cancer)
Gastroenterology Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial. sep. 17 4 ♥ Endoscopie/Imagerie
Gastroenterology Risk Stratification for Covert Invasive Cancer Among Patients Referred for Colonic Endoscopic Mucosal Resection: A Large Multicenter Cohort. sep. 17 3 ♥ Endoscopie - Imagerie
The American Journal of Gastroenterology Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. sep. 17 3 ♥ Pancréas/Voies biliaires
Gut Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. sep. 17 3 ♥ Pancréas/Voies biliaires
The American Journal of Gastroenterology Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab sep. 17 3 ♥ MICI
The American Journal of Gastroenterology Rural and Urban Residence During Early Life Is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study sep. 17 4 ♥ MICI
The Lancet Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial sep. 17 3 ♥ MICI
Inflammatory Bowel Diseases Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Cro sep. 17 3 ♥ MICI

Pages